Johnson and Johnson

Related Content

News | FDA
FDA Approves Johnson & Johnson OPSYNVI (macitentan and tadalafil) Single-Tablet Combination for Patients with Pulmonary Arterial Hypertension (PAH)

March 27, 2024 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI – ...

Home March 27, 2024
arrow
Regulatory approval for the first fully integrated PFA system with a CARTO-enabled simple and reproducible workflow
News | Stroke
Biosense Webster Announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation (PFA) Platform

March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 05, 2024
arrow
Innovative investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation
News | Atrial Fibrillation
Johnson & Johnson MedTech Acquires Laminar, Inc.

November 30, 2023 — Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a ...

Home November 30, 2023
arrow
Study will evaluate the safety and effectiveness of the OMNYPULSE Pulsed Field Ablation (PFA) platform with integrated mapping
News | Cardiovascular Clinical Studies
Biosense Webster Begins Evaluation of Large-tip Focal Pulsed Field Ablation Catheter in Omny-IRE Clinical Trial in Europe

September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home September 18, 2023
arrow
Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.
News | Cardiovascular Business
Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now ...

Home December 22, 2022
arrow
Johnson & Johnson to Acquire Abiomed
Feature | Cardiovascular Business
Johnson & Johnson to Acquire Abiomed

November 1, 2022 — Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support ...

Home November 01, 2022
arrow
ECG showing Atrial Fibrillation
News | Atrial Fibrillation
First Patients in the U.S. Enrolled in Biosense Webster Clinical Study To Evaluate VARIPULSE Catheter for Atrial Fibrillation

May 2, 2022 – Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science ...

Home May 02, 2022
arrow
News | Balloon Catheter
CERENOVUS Launches EMBOGUARD Balloon Guide Catheter to Use In the Treatment of Acute Ischemic Stroke

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
arrow
CDC and FDA Call for Pause on Janssen COVID-19 Vaccine Due to Rare Blood Clots #COVID19 #Janssen
Feature | Coronavirus (COVID-19)| By Dave Fornell, Editor
CDC and FDA Call for Pause on Janssen COVID-19 Vaccine Due to Rare Blood Clots

(This story was updated May 7, 2021 in the last subheaded section) April 13, 2021 — The U.S. Food and Drug ...

Home April 13, 2021
arrow
Xarelto Reduces Blood Clot Events in High-Risk Cancer Patients
News | Cardio-oncology
Xarelto Reduces Blood Clot Events in High-Risk Cancer Patients

December 7, 2018 — New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE ...

Home December 07, 2018
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now